Asset Details
Do you wish to reserve the book?
Mismatch repair deficiency is not sufficient to elicit tumor immunogenicity
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Mismatch repair deficiency is not sufficient to elicit tumor immunogenicity
Do you wish to request the book?
Mismatch repair deficiency is not sufficient to elicit tumor immunogenicity
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Mismatch repair deficiency is not sufficient to elicit tumor immunogenicity
2023
Overview
DNA mismatch repair deficiency (MMRd) is associated with a high tumor mutational burden (TMB) and sensitivity to immune checkpoint blockade (ICB) therapy. Nevertheless, most MMRd tumors do not durably respond to ICB and critical questions remain about immunosurveillance and TMB in these tumors. In the present study, we developed autochthonous mouse models of MMRd lung and colon cancer. Surprisingly, these models did not display increased T cell infiltration or ICB response, which we showed to be the result of substantial intratumor heterogeneity of mutations. Furthermore, we found that immunosurveillance shapes the clonal architecture but not the overall burden of neoantigens, and T cell responses against subclonal neoantigens are blunted. Finally, we showed that clonal, but not subclonal, neoantigen burden predicts ICB response in clinical trials of MMRd gastric and colorectal cancer. These results provide important context for understanding immune evasion in cancers with a high TMB and have major implications for therapies aimed at increasing TMB.
Mouse models of lung and colorectal cancer with sporadic DNA mismatch repair deficiency clarify that the intratumor heterogeneity and clonal architecture rather than tumor mutational burden are powerful determinants of immunotherapy response.
Publisher
Nature Publishing Group US,Nature Publishing Group
Subject
/ 13/31
/ 13/51
/ 38/22
/ 38/23
/ 45/23
/ 45/41
/ 64/110
/ 64/60
/ 82/58
/ Animal Genetics and Genomics
/ Animals
/ Antigens, Neoplasm - genetics
/ Biomarkers, Tumor - genetics
/ Biomedical and Life Sciences
/ Cloning
/ Colorectal Neoplasms - genetics
/ DNA Mismatch Repair - genetics
/ Immune checkpoint inhibitors
/ Mice
/ Mutation
/ Neoplastic Syndromes, Hereditary
/ Tumors
/ Yeast
We currently cannot retrieve any items related to this title. Kindly check back at a later time.